|
 |
Recent CABS Activity
RNA and DNA-based Therapeutics: Opportunities, Challenges and IP Issues
Date:
2010-04-10
Time:
12:30 -1:00PM check-in 1:00- 5:00 PM presentations
Location:
Conference Room at Orrick, 1100 Marsh Road, Menlo Park, CA 94025
Description:
Outline: This 4-hour workshop is dedicated to the topics of nucleic acid-based therapeutics. There will be 5 presentations covering siRNA, miRNA, DNA therapeutics, and intellectual property considerations. We expect to hear from the experts about this emerging class of novel therapeutics, the opportunities as well as challenges.
Workshop Agenda:
12:30 - 1:00 PM Check-in & Networking
1:00 - 1:10 PM Welcome remarks, Dr. Shichang Miao, President of CABS
1:10 - 1:20 PM Overview, Hua Tu, PhD, Co-chair, CABS Science Committee
1:20 - 2:00 PM "Development of RNAi Therapeutics: Opportunities and Challenges", Joe Zhou, MD, PhD, Director, Silence Therapeutics
2:00 - 2:40 PM "miRNA as Therapeutic Target", Chang-Zheng Chen, PhD, Assistant Professor, Stanford University
2:40 - 3:00 PM Break
3:00 - 3:40 PM "BHT-DNA Platform Technology for the Treatment of Autoimmune Disorders", Hideki Garren, MD, PhD, COO/CSO, Bayhill Therapeutics
3:40 - 4:20 PM "Nucleic Acid-based Therapeutics Development Programs in China",
Jinkang Wang, PhD, Executive VP, Biomics Biotechnologies, China
4:20 - 5:00 PM "IP issues Related to Nucleic Acid-based Therapeutics", Liz Howard, PhD, JD, Partner, Orrick
Registration Requirement:
$5 online for CABS active members; $10 on-site
$15 online for inactive or non-members; $20 on-site
Presentation handout at $10 - online only
Sponsors:
Please sign up online for major sponsorship or vendor show
Organizers:
CABS
|
|
|
|
